Sarpogrelate is selective for 5-HT 2 (pK i =7.54) over 5-HT 1 (pK i =4.58), α 1 -, α 2 -, and β-adrenergic (pK i =3.17-6.19), and muscarinic receptors (pK i =4.39). Sarpogrelate (10 μM) significantly reduces the number of platelet-rich plasma (PRP)-induced THP-1 cell that adheres to human umbilical vein endothelial cells (HUVECs). Sarpogrelate (10 μM) significantly reduces the expression of PRP-induced E-selectin in HUVECs.
广州市齐云生物技术有限公司
联系商家时请提及chemicalbook，有助于交易顺利完成！